244 related articles for article (PubMed ID: 37476937)
1. Application of organic nanocarriers for intraocular drug delivery.
Chang W; Shen J; Liu Z; Chen Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):259-266. PubMed ID: 37476937
[TBL] [Abstract][Full Text] [Related]
2. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
3. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
5. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
[TBL] [Abstract][Full Text] [Related]
7. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.
Han H; Li S; Xu M; Zhong Y; Fan W; Xu J; Zhou T; Ji J; Ye J; Yao K
Adv Drug Deliv Rev; 2023 May; 196():114770. PubMed ID: 36894134
[TBL] [Abstract][Full Text] [Related]
8. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
9. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
10. Controlled drug release from lung-targeted nanocarriers via chemically mediated shell permeabilisation.
Chen H; Woods A; Forbes B; Jones S
Int J Pharm; 2016 Sep; 511(2):1033-41. PubMed ID: 27506512
[TBL] [Abstract][Full Text] [Related]
11. Nano-drug delivery system for the treatment of acute myelogenous leukemia.
Zhang S; Sun J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321
[TBL] [Abstract][Full Text] [Related]
12. Advance of the application of nano-controlled release system in ophthalmic drug delivery.
Wang X; Wang S; Zhang Y
Drug Deliv; 2016 Oct; 23(8):2897-2901. PubMed ID: 26635087
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
[TBL] [Abstract][Full Text] [Related]
15. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
Majumder J; Minko T
Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
18. Engineered therapeutic proteins for sustained-release drug delivery systems.
Nguyen TTK; Pham KY; Yook S
Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
[TBL] [Abstract][Full Text] [Related]
19. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.
Bisht R; Mandal A; Jaiswal JK; Rupenthal ID
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28425224
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release.
Liu J; Cabral H; Mi P
Adv Drug Deliv Rev; 2024 Apr; 207():115239. PubMed ID: 38437916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
